Attractive stocks have exceptional fundamentals. In the case of Bruker Corporation (NASDAQ:BRKR), there's is a company with great financial health as well as a a great history of performance. In the following section, I expand a bit more on these key aspects. For those interested in understanding where the figures come from and want to see the analysis, read the full report on Bruker here.
Outstanding track record with adequate balance sheet
In the past couple of years, BRKR has ramped up its bottom line by over 100%, with its latest earnings level surpassing its average level over the last five years. This illustrates a strong track record, leading to a satisfying return on equity of 21%, which paints a buoyant picture for the company. BRKR's strong financial health means that all of its upcoming liability payments are able to be met by its current cash and short-term investment holdings. This indicates that BRKR has sufficient cash flows and proper cash management in place, which is an important determinant of the company’s health. BRKR appears to have made good use of debt, producing operating cash levels of 0.37x total debt in the prior year. This is a strong indication that debt is reasonably met with cash generated.
For Bruker, there are three important aspects you should further examine:
- Future Outlook: What are well-informed industry analysts predicting for BRKR’s future growth? Take a look at our free research report of analyst consensus for BRKR’s outlook.
- Valuation: What is BRKR worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether BRKR is currently mispriced by the market.
- Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of BRKR? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at email@example.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.